Page last updated: 2024-10-31

midazolam and Hepatitis B, Chronic

midazolam has been researched along with Hepatitis B, Chronic in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

Research Excerpts

ExcerptRelevanceReference
"Ritonavir is a powerful inhibitor of cytochrome P450 3A (CYP3A) that metabolizes many antiretrovirals."2.73Ritonavir greatly impairs CYP3A activity in HIV infection with chronic viral hepatitis. ( Greenblatt, DJ; Kaufman, RC; Knox, TA; Oleson, L; von Moltke, LL; Wanke, CA, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knox, TA1
Oleson, L1
von Moltke, LL1
Kaufman, RC1
Wanke, CA1
Greenblatt, DJ1

Trials

1 trial available for midazolam and Hepatitis B, Chronic

ArticleYear
Ritonavir greatly impairs CYP3A activity in HIV infection with chronic viral hepatitis.
    Journal of acquired immune deficiency syndromes (1999), 2008, Dec-01, Volume: 49, Issue:4

    Topics: Administration, Oral; Adult; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome

2008